Literature DB >> 7192152

Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes.

L Fletcher, J L Maddocks.   

Abstract

1 A specific assay for the measurement of thioinosinic acid, in human lymphocytes, has been developed with a sensitivity of 50 ng of thioinosinic acid per 5 x 10(6) lymphocytes. 2 Thioinosinic acid is precipitated from purified lymphocytes as the lanthanum salt. Acid hydrolysis results in the formation of 6-mercaptopurine which, when converted into its phenyl mercury derivative, can be easily extracted into toluene. Back-extraction of the toluene layer with 0.1N HCl regenerates 6-mercaptopurine which is then assayed fluorometrically. 3 Blood samples were taken from renal transplant recipients 3 h after an oral dose of 50 mg azathioprine. The results from 5 patients gave a range of 54 to 173 ng of thioinosinic acid per 5 x 10(6) lymphocytes, with a mean of 110 ng. 4 In an in vitro incubation of azathioprine, 1mM with fresh human blood, 160 and 180 ng of thioinosinic acid per 5 x 10(6) lymphocytes was formed after 0.5 h and 5 h respectively. 5 The assay is suitable for the study of the kinetics of thioinosinic acid formation in lymphocytes of patients with kidney transplants. It could also prove useful in the study of thioinosinic acid formation in leukaemia patients undergoing 6-mercaptopurine treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192152      PMCID: PMC1430061          DOI: 10.1111/j.1365-2125.1980.tb01757.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The formation of 6-mer captopurine riboside phosphate in ascites tumor cells.

Authors:  A R PATERSON
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Separation and detection of picomole quantities of azathioprine metabolites.

Authors:  J L Maddocks; G S Davidson
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Separation of 6-thiopurine derivatives on DEAE-sephadex columns and in the high-pressure liquid chromatograph.

Authors:  D J Nelson; C J Bugge; H C Krasny; T P Zimmerman
Journal:  J Chromatogr       Date:  1973-03-14

5.  The metabolic fate of the methylnitroimidazole moiety of azathioprine in the rat.

Authors:  P De MIRANDA; L M Beacham; T H Creagh; G B Elion
Journal:  J Pharmacol Exp Ther       Date:  1973-12       Impact factor: 4.030

Review 6.  Metabolic basis for the actions of analogs of purines and pyrimidines.

Authors:  G B Elion; G H Hitchings
Journal:  Adv Chemother       Date:  1965

7.  Ion-exchange chromatography of tissue nucleotides.

Authors:  I C Caldwell
Journal:  J Chromatogr       Date:  1969-10-28

Review 8.  Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

Authors:  G B Elion
Journal:  Fed Proc       Date:  1967 May-Jun

9.  Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation.

Authors:  A C Allison; T Hovi; R W Watts; A D Webster
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

10.  Assay of azathioprine, 6-mercaptopurine and a novel thiopurine metabolite in human plasma.

Authors:  J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

View more
  3 in total

1.  Colitic cancer developed after introduction of azathioprine.

Authors:  Jun-ichi Sasaki; Yutaka J Kawamura; Fumio Konishi; Tsutomu Tosha
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

2.  6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.

Authors:  S Herber; L Lennard; J S Lilleyman; J Maddocks
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

3.  Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.

Authors:  J S Lilleyman; L Lennard; C A Rees; G Morgan; J L Maddocks
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.